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INTRODUCTION 
 
Proteins are frequently misfolded during the lifetime of 
a cell, as a consequence of stochastic fluctuations of the 
structures, genomic mutations, oxidation or other 
different stress conditions [1]. Misfolded proteins often 
tend to aggregate due to the exposure of hydrophobic 
amino acid residues and unstructured polypeptide 
backbones, which are shielded in a native conformation 
[2]. Accumulation of misfolded proteins within cellular 
compartments or tissues is emerging as a major 
contributor or even a causative agent in human diseases 
which are called “conformational diseases” [3]. These 
include a diverse array of pathologies such as lysosomal 
storage diseases [4], cystic fibrosis [5] and many 
neurodegenerative disorders [6, 7]. To minimize the 
detrimental effects that misfolded and aggregated 
proteins impose, cells have evolved efficient protein 
quality control (PQC) systems to maintain proteostasis, 
which consist of the ubiquitin-proteasome system 
(UPS), chaperone mediated autophagy (CMA) and 
autophagy [8]. 
 
UPS is the major selective proteolytic system in 
eukaryotic cells, which degrades short-lived regulatory 
proteins and soluble misfolded proteins [9]. The 
conjugation of a polyubiquitin chain to target proteins is 
an essential step for their degradation by the 26S 
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UBB+1 is a mutated version of ubiquitin B peptide caused by a transcriptional frameshift due to the RNA 
polymerase II “slippage”. The accumulation of UBB+1 has been linked to ubiquitin-proteasome system (UPS) 
dysfunction and neurodegeneration. Alzheimer’s disease (AD) is defined as a progressive neurodegeneration 
and aggregation of amyloid-β peptides (Aβ) is a prominent neuropathological feature of AD. In our previous 
study, we found that yeast cells expressing UBB+1 at lower level display an increased resistance to cellular 
stresses under conditions of chronological aging. In order to examine the molecular mechanisms behind, here 
we performed genome-wide transcriptional analyses and molecular/cellular biology assays. We found that low 
UBB+1 expression activated the autophagy pathway, increased vacuolar activity, and promoted transport of 
autophagic marker ATG8p into vacuole. Furthermore, we introduced low UBB+1 expression to our humanized 
yeast AD models, that constitutively express Aβ42 and Aβ40 peptide, respectively. The co-expression of UBB+1 
with Aβ42 or Aβ40 peptide led to reduced intracellular Aβ levels, ameliorated viability, and increased 
chronological life span. In an autophagy deficient background strain (atg1∆), intracellular Aβ levels were not 
affected by UBB+1 expression. Our findings offer insights for reducing intracellular Aβ toxicity via autophagy-
dependent cellular pathways under low level of UBB+1 expression. 
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proteasome. Increasing evidences show that impaired 
and/or decreased function of the UPS is associated with 
many neurodegenerative diseases including Alzheimer’s 
disease (AD) [10], Parkinson’s disease (PD) and 
Huntington’s disease (HD) [11]. In addition to disease-
causing proteins (e.g., amyloid β, alpha-synuclein, or 
Huntingtin), there are often disruptions in the Ubiquitin 
B gene (UBB) and mRNA transcripts, as well as 
polyubiquitin depositions within aggregates made of 
disease-specific proteins. UBB+1 is generated from a 
dinucleotide loss in the transcript due to RNA 
polymerase “slippage” during the transcription of the 
UBB gene, a process termed “molecular misreading”. 
The hotspots for molecular misreading are near short 
repeat sequence, such as the GAGAG motif [12]. The 
result of misreading is a frameshift near 3’ end of UBB 
mRNA transcript resulting in UBB+1, a UBB peptide 
variant with additional 20 amino acids at the C-
terminus. Unlike the UBB, UBB+1 fails to ligate protein 
substrates or join polyubiquitin chains due to the 
absence of the C-terminal glycine residue, but like any 
other damaged protein recognized by the UPS system, it 
is readily ubiquitylated and degraded [13, 14]. 
 
AD is the most common form of neurodegeneration in 
aging population [15]. The accumulation of amyloid-β 
(Aβ) plaques in the brain is one of principal hallmarks 
of AD, which is thought to trigger a cascade of 
pathogenic processes [16]. Accumulation of UBB+1 is a 
cellular hallmark of sporadic and autosomal AD cases, 
suggesting its pathological contribution [17, 18]. The 
presence of UBB+1 has been proposed as an endogenous 
reporter for decreased UPS activity [19]. Previous 
studies showed that UBB+1 acts as a ubiquitin-fusion-
degradation substrate for the proteasome and its 
properties shift from substrate to inhibitor, in a dose-
dependent manner [14, 20]. Low levels of UBB+1 can be 
ubiquitinated and efficiently degraded by the UPS, 
whereas at high levels, the UPS fails to degrade UBB+1 
and the accumulation of UBB+1 further induces 
functional impairment of the UPS. Prolonged 
expression of high levels of UBB+1 affects 
mitochondrial dynamics and triggers neuronal cell death 
[21, 22]. Despite the UBB+1-induced UPS dysfunction, 
in some cases UBB+1 expression is protective by the 
induction of heat-shock proteins, which promote 
cellular resistance to oxidative stress [23, 24]. UBB+1 
expression reduces the Aβ plaque load in APPPS1 mice 
during aging through restoration of PS1-NTF 
expression and γ-secretase activity [25]. 
 
Although the impact of UBB+1 has been studied in 
different in vivo model systems, the precise role of 
UBB+1 in UPS dysfunction and its importance during 
AD progression remains ambiguous. The yeast 
Saccharomyces cerevisiae is a powerful eukaryotic 
model often used to study misfolded proteins and their 
implication in human pathologies due to the strong 
conservation of PQC systems between yeast and human 
cells [26]. To exploit the effects of UBB+1 expression 
on proteasome function and cellular viability, we 
recently developed two yeast models using constitutive 
expression of the human UBB+1, expressed at high and 
low levels [27]. We found that at low expression level, 
UBB+1 enhances cellular resistance to misfolded 
proteins and oxidative stress during chronological 
aging, and prolongs chronological life span (CLS), 
which measures the survival time of nondividing cells 
[27]. Aβ42 and Aβ40 are two major isoforms of Aβ 
associated with AD. Aβ40 is found in higher quantities 
in the affected brain tissue, but Aβ42 is more 
hydrophobic and more prone to aggregation. To mimic 
the chronic cytotoxicity of Aβ isoforms accumulation in 
AD progression, we have developed two humanized 
yeast AD models with Aβ42 and Aβ40 expression, 
respectively [28, 29]. These models have been used as a 
platform for synthetic genetic array (SGA) to screen for 
modulators of Aβ42 toxicity [30]. 
 
Here we take advantage of our low UBB+1 expression 
strain (hereafter referred to as L-UBB+1 strain) to 
investigate the underlying mechanisms that protect cells 
from stresses that we have previously identified [27] by 
using the genome-wide transcriptional analyses, 
followed by several molecular and cell biology assays. 
Transcriptome analyses helped to generate the 
hypotheses which were tested, which then led us to that 
low UBB+1 expression activated the autophagy 
pathway, which then reduced intracellular Aβ levels and 




Low expression of human UBB+1 significantly 
modifies the transcription of thousands of genes 
 
We have previously shown that at low expression levels, 
UBB+1 can extend CLS and increase cellular tolerance to 
misfolded proteins in yeast [27]. To investigate the 
mechanisms behind the observed phenotypes, we further 
performed a genome-wide transcriptional study and 
compared the gene expression between the control strain 
(carrying an empty vector) and the L-UBB+1 strain, 
during the exponential growth phase (EX) and stationary 
phase (D6, i.e., 6 days after carbon source in the medium 
has been used up). The principal component analysis 
(PCA) showed distinct gene expression profile between 
control strain and L-UBB+1 strain (Figure 1A and 
Supplementary Figure 1). Pair-wise comparisons of L-
UBB+1 strain and control strain revealed that 2212 and 
2350 genes were significantly differentially expressed 
(adj-P < 0.001 and log2FC ≤ -1 or log2FC ≥ 1) during EX 
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and D6, respectively (Figure 1B and 1C). 1913 genes 
(72.2%) were significantly changed during both EX and 
D6 phases. 
 
To gain more insight into biological processes affected 
by L-UBB+1 expression, we also performed the gene set 
enrichment analysis (GSA) on the significantly 
differentially expressed genes. In the L-UBB+1 strain, 
23 and 29 gene sets were significantly upregulated and 
downregulated, respectively, in EX and D6 phases, 
compared to the control strain (adj-P < 0.05, 
Figure 1D). Gene sets associated with autophagy and 
ubiquitin-related processes, such as “protein 
ubiquitination”, “ubiquitin-dependent protein 
catabolism”, “SCF-dependent proteasomal protein 
catabolism” and “ubiquitin-protein transferase activity”, 
were enriched among upregulated genes in the L-UBB+1 
strain. Our previous study showed the L-UBB+1 
expression inhibits proteolytic activities of 20S 
proteasome [27]. The inhibition of proteasome results in 
the compensatory activation of UPS and autophagy 
[31], which is in accordance with our genome-wide 
transcriptional analysis results. Gene sets related to 




Figure 1. The global transcriptional response to constitutively low UBB+1 expression. (A) Principal Component Analysis (PCA) of 
the normalized microarray data. (B–C) Volcano plot of log2(FC) (Fold change) vs adjusted p value of differentially expressed genes 
comparing L-UBB+1 strain and control strain during EX (B) and D6 (C). The dashed vertical grey line indicates the threshold of log2(FC) (≤ -1 
or ≥ 1), while the horizontal grey line indicates statistical significance threshold of adjusted p value < 0.05. (D) The significantly enriched GO 
terms in L-UBB+1 strain compared to control strain during EX and D6 phases. The red color indicates upregulated processes and blue color 
indicates downregulated processes. Samples are biological duplicates.  
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“transcription by RNA polymerase II”, “positive 
regulation of transcription by RNA polymerase II”, 
were enriched among upregulated genes as well (adj-P 
< 0.05, Figure 1D and Supplementary Figures 2 and 3). 
Whereas gene sets related to protein synthesis 
pathways, such as “translation”, “protein 
glycosylation”, “GPI anchor biosynthetic process”, “ER 
to Golgi transport”, “translocation”, were enriched 
among downregulated genes in the L-UBB+1 strain (adj-
P < 0.05, Figure 1D and Supplementary Figures 2 and 
3), which may alleviate the ER stress by reducing the 
influx of newly synthesized proteins into ER. In 
addition to these protein syntheses and processing 
related processes, genes related to metabolic process, 
such as “lipid biosynthetic process”, “nucleotide 
biosynthetic processes” and “glycolytic process”, were 
significantly downregulated in the L-UBB+1 strain (adj-
P < 0.05, Figure 1D and Supplementary Figures 2 
and 3). 
 
Low expression of human UBB+1 significantly 
increases the transcription of autophagy genes 
 
Gene sets related to autophagy processes were 
significantly upregulated in the L-UBB+1 strain (Figure 
2 and Supplementary Table 1). Autophagy is a major 
catabolic pathway which critically secures eukaryotic 
cellular homeostasis and survival [32]. Activation of 
autophagy extends the lifespan of many other model 
systems such as the nematode Caenorhabditis elegans 
[33], fruit fly Drosophila melanogaster [34] and mice 
[35], and protects cells against a variety of stresses 
[36, 37]. Macroautophagy is the most prevalent form of 
autophagy in which double-membrane structures called 
the autophagosomes are formed around cargoes 
designated for degradation, such as aberrant organelles 
and misfolded/aggregated proteins [38]. It starts with 
the appearance of an isolated membrane termed the pre-
autophagosomal structure [39], which expands and seals 
itself into an autophagosome while engulfing bulk 
portions of cytoplasm. Upon fusion with the vacuole, 
the inner autophagosome contents are degraded by 
lysosomal hydrolases (Figure 2A). About 35 autophagy-
related genes (ATG) have been identified in yeast [40]. 
Among these, 18 ATG genes in six functional groups 
are required for autophagosome formation: the Atg1 
complex, Atg9, the autophagy-specific 
phosphatidylinositol 3-kinase (PI3K) complex, the 
Atg2-Atg18 complex, and the Atg8 and Atg12 
conjugation systems [41]. Compared to the control 
strain, 15 out of these 18 ATG genes were found 
significantly upregulated in the L-UBB+1 strain (adj-P < 
0.05, Figure 2B). The expression level of ATG1, an 
essential regulator required for the formation of the 
autophagosome in yeast [42], was 7.03 and 5.86-fold 
higher in the L-UBB+1 strain during the EX phase and 
D6 phase, respectively (Supplementary Table 2). qPCR 
(quantitative PCR) analysis verified that the transcript 
level of ATG1 was 7.33-fold higher in L-UBB+1 strain 
during EX phase (p < 0.001, Supplementary Figure 4). 
 
Most genes involved in “regulation of autophagy” and 
“cvt pathway”, “pexophagy”, “mitophagy” and 
“micronucleophagy” were also significantly upregulated 
in the L-UBB+1 strain (Figure 2C). Higher transcription 
levels of 10 autophagy related genes were further 
verified by qPCR analysis (Supplementary Figure 5). 
For illustration, 81 differentially expressed genes 
involved in autophagy related processes are listed in 
Supplementary Table 2. 
 
Low expression of human UBB+1 activates 
autophagy 
 
To investigate whether the expression of L-UBB+1 led 
to an actual activation of the autophagy pathway, 
autophagy was monitored by measuring the cleavage of 
a GFP-Atg8 fusion protein. Atg8p is a protein essential 
for autophagy, which is transported to the vacuole for 
degradation during autophagy. The proteolysis of GFP-
Atg8 releases an intact GFP, which can be detected and 
correlated with the autophagic rate [43]. The cleavage 
of GFP-Atg8 was assessed at mid EX phase in both 
control strain and L-UBB+1 strain. No cleavage of GFP 
was observed in control strain. In contrast, 36% of free 
GFP was detected in the L-UBB+1 strain, indicating the 
activation of autophagy (Figure 3A and 3E). Nitrogen 
starvation and rapamycin treatment are two known 
activators of autophagy [44], which resulted in 90% and 
59% of free GFP cleavage in our control strain, 
respectively (Figure 3A and 3E). When we analyzed the 
GFP-Atg8 cleavage in autophagy deficient mutant 
(atg1∆) background, no GFP-Atg8 cleavage was 
observed in the atg1∆_L-UBB+1 strain, similar to the 
results from nitrogen starvation and rapamycin 
treatment in atg1∆_control strain (Figure 3B). This 
indicates that the Atg1p is involved in L-UBB+1-
induced activation of autophagy. Fluorescent 
microscopy was used to study the localization of GFP-
Atg8p. Since GFP is relatively resistant to degradation, 
it accumulates in the vacuole as autophagy proceeds. In 
the L-UBB+1 strain, 24.1% of cells showed diffused 
GFP fluorescence in the vacuole (Figure 3C and 3F), 
which was significantly higher than 6% in the control 
strain (Figure 3C and 3F). The nitrogen starvation and 
rapamycin treatments in control strain showed 
respectively 91.1% and 83.2% of cells with stronger 
GFP fluorescence inside the vacuoles (Figure 3C and 
3F). In the atg1∆ mutant strain, the accumulation of 
GFP fluorescence in the vacuole was absent under the 
same treatments (Figure 3D and 3F), revealing the 
inability of mutant cells to activate autophagy. 
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Autophagy was also monitored by following the bulk 
transport of cytosolic contents to vacuole for 
degradation using a FM 4-64 dye [45]. In the absence of 
autophagy, only the vacuolar perimeter was stained with 
FM 4-64 (Figure 4A). Under autophagy-induced 
conditions, cells showed intravacuolar staining and 
multivesicular bodies. Nitrogen starvation and 
rapamycin treatment resulted in 94.1% and 81.2% of 
cells showing such intravacuolar staining, respectively 
(Figure 4A and 4C). For the L-UBB+1 strain, 29% of the 
cell population showed intravacuolar staining (Figure 
4A and 4C), which was significantly higher than the 
control strain (p < 0.05). In the atg1∆ mutant 
background, there was no significant intravacuolar 
staining neither with L-UBB+1 expression, nor under 
nitrogen starvation and rapamycin treatment 
(Figure 4B and 4C). 
 
Low expression of human UBB+1 significantly 
extends chronological life span 
 
Beyond its function in turn-over and renewal of cellular 
contents, autophagy plays a prominent role in the life 
span of many model organisms. Multiple reports 
indicate that a plethora of nutritional, pharmacological, 
or genetic manipulations that increase life span often 
stimulate autophagy, whereas inhibition of autophagy is 
associated with accelerated aging [34, 46, 47]. To 
determine whether the L-UBB+1 expression-induced 
autophagy led to alterations in life span, we performed 
CLS analyses to the control, L-UBB+1, atg1∆ and 
atg1∆_L-UBB+1 strains. The number of surviving cells 
were determined by colony forming unit (CFU) 
counting (Figure 5A) and PI staining (Figure 5B). 
Compared to the control strain, the L-UBB+1 strain 
displayed a significantly greater survival after 5 days 
and the CLS extended from 13 days to 15 days (p < 
0.01, Figure 5A). However, this markedly extended life 
span was abrogated when ATG1 was deleted and life 
span was shortened to 11 days in atg1∆_L-UBB+1 strain 
(Figure 5A). The source data for Figure 5A was 
provided in Supplementary Table 3. In accordance with 
this, the PI staining showed significantly decreased 
fractions of dead cells in L-UBB+1 culture on day 6 and 
day 9 compared to the control strain (p < 0.01, 




Figure 2. Low UBB+1 expression activates autophagy at the transcript level. (A) Schematic overview of autophagosome formation. 
(B) Fold changes in the expression of ATG genes encoding for autophagosome formation. Abbreviation: PI3K, phosphatidylinositol 3-kinase. 
(C) Fold changes in the expression of genes encoding different modes of autophagy. All comparison is between L-UBB+1 strain and control 
strain during EX and D6 phases (adj-p < 0.05).  
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lower in L-UBB+1 strain than control strain at day 9 
(Figure 5B). 
 
Low expression of human UBB+1 significantly 
reduces Aβ levels and cytotoxicity 
 
In previous study, we developed yeast Aβ models that 
mimic the chronic cytotoxicity of the amyloid peptides 
[28]. The expression of two major Aβ peptides, Aβ40 and 
Aβ42, interferes with cellular metabolism and causes 
different levels of ER stress which regulate cell fate [29]. 
Here we took advantage of these established Aβ models to 
investigate whether the L-UBB+1 expression could affect 
the different Aβ toxic isoforms. Immunostaining 
confirmed the localization of Aβ in the ER/secretory 
compartment (Figure 6A and Supplementary Figure 6A). 
In the Aβ42 expression strain, Aβ concentrated in small 
foci (Figure 6A), compared to a more disperse distribution 
in the Aβ40 strain (Supplementary Figure 6A), as we 




Figure 3. Low UBB+1 expression activates autophagy. (A–B) Western blot of GFP-Atg8p processing into free GFP. GAPDH was used as 
the loading control. (C–D) Translocation of GFP-Atg8p into yeast vacuole. Top panel: images from FLUO-GFP filter. Bottom panel: images 
from DIC filter. White arrow: GFP fluorescence inside vacuole. Scale bar = 5 µm. (E) The ratio of free GFP to total GFP (uncleaved GFP-ATG8 
+ free GFP) under wild type background was calculated and presented based on (A). Data is shown as average values ± SD from biological 
triplicates. (F) The percentage of cells with diffuse vacuolar GFP fluorescence was counted and represented based on (C–D). Above 200 cells 
were count per sample (n = 3 ± SD).  The asterisk (*) indicates a statistically significant p-value of < 0.05 from untreated control strain. 
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the Aβ42 strain (Figure 6B) when protein lysates were not 
subjected to boiling, which disrupts the oligomers.  In the 
Aβ40 strain, only monomer and dimer were observed in 
unboiled samples (Supplementary Figure 6B). This clearly 
illustrates the different capacity of both peptides to form 
aggregates. When L-UBB+1 was co-expressed in the Aβ42 
and Aβ40 strains, a significant reduction in the 
immunostaining fluorescence was observed in both Aβ42 
(Figure 6A) and Aβ40 strains (Supplementary Figure 6A). 
L-UBB+1 expression significantly decreased Aβ levels in 
the Aβ42 strain (p < 0.05, Figure 6B and 6C) as 
determined by immunoblotting. The Aβ40 strain was less 
sensitive to L-UBB+1 expression, which led to a milder 
reduction of Aβ40 levels (p < 0.05, Supplementary Figure 
6B and 6C). 
 
The reduced intracellular Aβ42 and Aβ40 levels might 
in part be due to enhanced autophagy upon L-UBB+1 
expression. In the atg1∆ mutant strain, L-UBB+1 co-
expression did not significantly alter Aβ levels in 
neither Aβ42 strain (Figure 6) nor Aβ40 strain 
(Supplementary Figure 6), indicating that activated 
autophagy was important for reduced Aβ levels upon L-
UBB+1 expression. 
 
The Aβ42 strain displayed a 17% reduction of maximal 
specific growth rate, compared to the control strain, and 
a shortened CLS of 9 days compared to 13 days in the 
control strain (Figure 7A), in agreement with our 
previous observations [28]. L-UBB+1 expression did not 
restore the decreased maximal specific growth rate of 
the Aβ42 strain (data not shown), however it did 
significantly enhance the cell survival. The CLS was 
extended to 15 days in the Aβ42_L-UBB+1 strain 
compared to 9 days in the Aβ42 strain (Figure 7A). 
Although the Aβ40 strain did not show the notable 
differences in physiology from control strain [29], CLS 
was shortened to 11 days compared to 13 days in the 
control strain. L-UBB+1 co-expression also led to an 
extended CLS in the Aβ40 strain, which showed a 





Figure 4. Low UBB+1 expression increases vacuolar activity. Images of vacuole staining with FM 4-64 under wild type background (A) 
and atg1∆ mutant background (B). Top panel: FM 4-64 fluorescence. Bottom panel: overlay of DIC and FM 4-64 fluorescence images. White 
arrows indicate cells with intravacuolar staining. Scale bar = 5 µm. (C) Quantification of the percentage of cells containing intravacuolar 
staining in the indicated strains. The data are shown as average values ± SD from three independent experiments, with more than 200 cells 
per experiment. The asterisk (*) indicates significant differences from the untreated control strain (p < 0.05).  
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The atg1∆ mutant strain showed a shorter CLS 
compared to the control strain (Figure 7B). Deficient 
expression of ATG1 (Unc-51) has been shown to 
decrease the life span of C. elegans [48] and 
D.melanogaster [49]. Aβ42 and Aβ40 expression in an 
atg1∆ mutant background led to a similar and 
remarkably shorter CLS of 7 days (Figure 7B), 
indicating that absence of autophagy increases cellular 
susceptibility to Aβ toxicity. L-UBB+1 co-expression 
with Aβ42 or Aβ40 in the atg1∆ background strain 
increased cell survival (Figure 7B), however the effect 
was not as strong as that of co-expression in the wild 
type background (Figure 7A). The CLS was extended to 
11 days in both atg1∆_Aβ42_L-UBB+1 strain and 
atg1∆_ Aβ40_L-UBB+1 strain, with lower survival 
compared to atg1∆ mutant strain. This suggests that the 
Aβ toxicity attenuation by low UBB+1 expression is not 
solely determined by elevated autophagy, but probably 
involves a secondary mechanism. The source data for 




Humanized yeast models have been constructed and 
used to investigate molecular mechanisms underlying 
several human neurodegenerative disorders, by 
expressing human proteins implicated (or suspected to 
play a relevant role) in these diseases and studying the 
effects on yeast cell physiology, fitness, and different 
molecular pathways [50, 51]. UBB+1 has been found to 
accumulate in the brain of AD patients [52] and it is 
thus believed that it might contribute to the 
development of neuropathology of AD [53], thus a 
humanized yeast model by using heterologous 
expression of UBB+1 in yeast, could provide insights 
into its role(s) in vivo. We found that constitutive low 
levels of UBB+1 expression increase the capacity to 
degrade misfolded proteins and prevent cells to 
accumulate reactive oxygen species [27]. Here, we 
investigated the potential molecular mechanisms behind 
these effects by using genome-wide transcriptional 
analyses to generate hypotheses, which we tested by 
using molecular and cell biology tests. We found that 
the autophagy pathway was significantly upregulated in 
L-UBB+1 strain, which may therefore contribute to 
decreased intracellular Aβ42 and Aβ40 levels and 
attenuated Aβ-induced cytotoxicity. 
 
Autophagy is an evolutionarily conserved catabolic 
pathway used to degrade misfolded or aggregated 
proteins, as well as damaged cellular organelles, and is 
an important neuroprotective mechanism [54–56]. 
Neurons and glia in the central nervous system (CNS) 
are highly specialized post-mitotic cells that need to 
continuously remove defective proteins and organelles 
[57]. Cellular and animal models have shown that 
autophagy pathways are involved in the regulation of 
neurogenesis, and if they are not functional lead to 
neuronal disorders. Deficient autophagy in microglia 
results in impaired synaptic refinement and social 
behavioral defects [58, 59]. 
 
Our transcriptional analyses revealed that low 
expression of UBB+1 elevated the expression of genes 
involved in ubiquitin-related processes and autophagy 
pathways. Genes involved in macroautophagy and 
selective autophagy pathways were significantly 
upregulated (Figures 1 and 2). In addition, UBB+1 
expression increased the intravacuolar accumulation of 




Figure 5. Low UBB+1 expression extends ATG1-dependent CLS. (A) Survival of the L-UBB+1 strain during stationary phase under wild 
type background and atg1∆ mutant background. Viability was determined by CFU counting. (B) Percentages of dead cells are shown as the 
fraction of propidium iodine (PI) positive cells. The data are shown as mean ± SD from biological duplicates. *p < 0.01. 
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indicating increased vacuolar activity (Figure 4). 
Analysis of distribution and cleavage of GFP-Atg8 
showed that UBB+1 expression promoted the uptake of 
Atg8 into vacuole and the cleavage of free GFP from 
the GFP-Atg8 fusion (Figure 3). This process occurs 
during autophagy where GFP-Atg8 is engulfed by the 
completed autophagosomes and then degraded [60]. 
Similar effects were observed with two known strong 
activators of autophagy, nitrogen starvation and 
rapamycin treatment (Figures 3 and 4), suggesting that 
low UBB+1 expression increases autophagy activity, but 
moderately. Impaired autophagy with reduced capacity 
to eliminate pathogenic proteins has been reported in 
many neurodegenerative disorders such as AD and PD 
[61]. Autophagy lysosomes are increased in early stages 
of AD, whereas impaired clearance of autophagic 
vesicles, e.g., maturation and transport of 
autophagosomes, and reduced lysosomal proteolysis, 
are observed in later stages of AD, which may 
contribute to Aβ accumulation [62, 63]. Activating 
autophagy by rapamycin treatment, an inhibitor of 
mTOR pathway, protects neuroblastoma cells from Aβ 
toxicity [64], reduces cerebral Aβ load and slows AD 
progression in a transgenic AD mouse model [65]. Our 
data showed that low UBB+1 expression reduced 
intracellular levels of Aβ42 and Aβ40 in the wild type 
background but not in the atg1∆ mutant background 
(Figure 6 and Supplementary Figure 6), indicating that 
L-UBB+1 expression decreased Aβ levels as a function 
of autophagy activation. Activation of autophagy has 
been shown to protect cells against multiple forms of 
stress, including nutrient and growth factor deprivation, 
reactive oxygen species, endoplasmic reticulum stress, 




Figure 6. Low UBB+1 expression reduces Aβ42 levels in the humanized yeast AD model. (A) Immunostaining analysis of Aβ42 
localization and expression using the 6E10 Aβ specific antibody. Nuclei were stained blue by DAPI. Scale bar = 5 µm. (B) Western blot 
analysis of Aβ42 expression in unboiled cell lysates with 6E10 antibody. GAPDH was used as the loading control. (C) Relative Aβ42 band 
intensity was normalized to GAPDH and compared to the untreated Aβ42 strain. Results are reported as mean ± SD of three independent 
experiments. *p < 0.05.  
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observed that the low UBB+1 expression prolonged CLS 
in Aβ strains during chronological aging. The increased 
cell survival was reverted in the atg1∆ mutant 
background, further supporting the notion that 
activation of autophagy is crucial in promoting cellular 
survival and protection against Aβ induced toxicity. 
 
Besides the autophagy pathways, the genome-wide 
transcriptional analyses also revealed that many UPS-
related processes were activated in response to low 
UBB+1 expression. The UPS is a key component of the 
PQC for maintaining the proper concentrations of many 
regulatory proteins and clearing damaged/misfolded 
proteins [67]. Several studies suggest that sustained 
proteasome activity correlated with longevity, as found in 
centenarians [68], immortal cells such as human 
Embryonic Stem Cells (hESCs) [69], long-lived animals 
such as the naked mole-rat [70] and the giant clam [71]. 
The correlation has been further supported by genetic 
approaches. A genetic gain-of-function screening in D. 
melanogaster shows that rpn11, encoding a subunit of 
the 19S regulatory particle (RP), extends the flies’ life 
spans with suppression of accumulated ubiquitinated 
proteins during aging process [72]. Increased expression 
of rpn6, another subunit of the 19S RP, results in elevate 
proteasome activity, clearance of toxic PolyQ aggregated 
and increased longevity in C. elegans [73]. Rpn4 is 
required to induce proteasome subunits under conditions 
of proteasome dysfunction [74] and elevated rpn4 levels 
increase UPS capacity which enhances replicative 
lifespan and resistance to proteotoxic stress in yeast [75]. 
The expression levels of rpn11, rpn6 and rpn4 were 
significantly increased in the L-UBB+1 strain, which may 
additionally assist in reducing Aβ cytotoxicity. 
UPS and autophagy are two major protein degradation 
systems in eukaryotic cells, which aim at maintaining 
proteostasis. Recent studies strongly suggest functional 
crosstalk and interplay between these two systems. 
Autophagy can be activated in response to genetic or 
pharmacological inhibition of UPS [76]. With impaired 
proteasome function, the aberrant protein aggregates 
form large inclusion body-like structures known as 
aggresomes [77], which are thought to promote 
autophagy-mediated degradation [39]. Compensatory 
autophagy was induced in response to a dysfunctional 
UPS in a Drosophila model of the spinobulbar muscular 
atrophy via a histone deacetylase 6 (HDAC6)-
dependent aggresome pathway [78]. The molecular 
mechanisms underlying autophagy activation in 
response to UPS inhibition are not clear, but many 
factors may be involved, including the N-terminal 
arginylation of N-end rule pathway [79], the unfolded 
protein response [80], and the BCL family protein 
MCL1 (myeloid cell leukemia sequence 1) [81]. 
Previous studies have showed that UBB+1 is a dose-
dependent inhibitor of UPS [20]. We found previously 
that the overexpression of UBB+1 indeed decreases the 
proteolytic activities of the proteasome [27].  
 
Overall, our study shows that low UBB+1 expression 
significantly increased the autophagy activity and thus 
induced intracellular degradation of Aβ, which 
increased cell fitness and survival. Identifying how 
moderate induction of autophagy can significantly 
reduce Aβ accumulation and consequently reduce its 
cytotoxicity could be relevant for understanding better 
the molecular onset and progression of AD, as well as 




Figure 7. Low UBB+1 expression reduces Aβ42 and Aβ40 toxicity. (A) Survival of the Aβ42 and Aβ40 strains during stationary phase 
without or with low UBB+1 expression under wild type background. (B) Survival of the Aβ42 and Aβ40 strains during stationary phase 
without or with low UBB+1 expression under atg1∆ mutant background. Viability was determined by CFU counting. The data are shown as 
mean ± SD from biological duplicates.  
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MATERIALS AND METHODS 
 
Strains and cultivation 
 
The haploid laboratory strain S. cerevisiae CEN.PK113-
11C (MATα his3∆1 ura3-52 MAL2-8c SUC2) [82] was 
used as a reference strain in this study. The atg1∆ 
mutant strain was constructed by transforming the 
reference strain with a PCR amplified KanMX cassette 
(from the pUG6 plasmid [83]) including approximately 
500 bp upstream sequence and 500 bp downstream 
sequence flanks homologous to the ATG1 locus. The 
gene deletion was confirmed by PCR using primers 
outside the ATG1 open reading frame (ORF) and inside 
the KanMX gene respectively. All primers used are 
listed in the Supplementary Table 4. The previously 
described p413 TEF-UBB+1, p416 GPD-Kar2-Aβ42 and 
p416 GPD-Kar2-Aβ40 plasmids for constitutive 
expression of UBB+1, Aβ42 and Aβ40 respectively [27, 
28] were transformed into the reference strain and 
atg1∆ strain. The p413 TEF-EP plasmid [84] was 
transformed into the reference strain and atg1∆ strain to 
construct control strains. The pRS416 GFP-ATG8 
expression plasmid containing the GFP-Atg8 gene 
under the endogenous ATG8 promoter was donated by 
Prof. Daniel Klionsky, University of Michigan [85] 
(http://www.addgene.org/49425/, RRID:Addgene 
49425). All plasmids and yeast strains used in this study 
are summarized in Supplementary Table 5. 
 
All yeast transformations were performed following a 
standard lithium acetate method and transformants 
were selected on synthetic dextrose (SD) medium 
without histidine for L-UBB+1 strain (SD-His, 
Formedium, England), or without uracil for Aβ42 and 
Aβ40 strains (SD-Ura, Formedium, England), or 
without both histidine and uracil for L-UBB+1 and 
Aβ42/Aβ40 co-expression strains (SD-His-Ura, 
Formedium, England). For cultivation, strains were 
grown in liquid SD medium with 20 g l−1 glucose. 
Synthetic minimal medium without ammonium sulfate 
and amino acids (YNB (-N) medium, Formedium) 





Biological duplicate cultures from the control strain and 
L-UBB+1 strain were sampled during EX and D6 for 
microarray analysis. Cells were frozen immediately in 
liquid nitrogen for rapid quenching of mRNA turnover 
[86]. Cells were mechanically disrupted using a FastPrep 
homogenizer (MP Biomedicals, USA) and total RNA 
was extracted using the RNeasy Mini Kit (QIAGEN, 
Germany). Quality of total RNA was assessed using an 
RNA 6000 Nano LabChip Kit (Agilent Technologies, 
USA) with an Agilent 2100 Bioanalyzer (Agilent 
Technologies, USA). The labeled RNA was generated 
using the GeneChip® 3′ IVT Plus Reagent Kit 
(Affymetrix, USA), which was hybridized to GeneChip® 
Yeast Genome 2.0 Arrays (Affymetrix, USA). Staining 
and washing of the hybridized arrays were performed on 
the GeneChip® Fluidics Station 450 (Affymetrix, USA). 
Further microarrays were scanned in GeneChip® Scanner 
7G (Affymetrix, USA). RNA labelling, array 
hybridization and scanning were performed by the 
Bioinformatics and Expression Analysis core facility at 
Karolinska Institute, Sweden. Microarray data are 
available at the Genome Expression Omnibus website 
(GEO, http://www.ncbi.nlm.nih.gov/geo/) with the 
accession numbers GSE129688. The transcriptome data 
(CEL files) were analyzed using the R version 3.4.0 and 
the PIANO package (Platform for Integrative Analysis of 
Omics) with information from the Saccharomyces 
Genome Database (https://www.yeastgenome.org/) [87]. 
Gene set enrichment analysis (GSA) was performed to 
identify overrepresentation of functional annotation 
categories using the Database for Annotation, 
Visualization and Integrated Discovery (David, 
https://david.ncifcrf.gov/). The S288C yeast genome 
background was used to analyze the magnitude of fold 
enrichment. The differential gene expression (log2-FC) 
and corresponding significance (adjusted p-value) were 
calculated by the Benjamini–Hochberg method. 
Heatmaps of significantly differentially expressed genes 




Protein extraction and western blotting were 
performed as described previously [28]. 5 OD600 nm of 
cells were spun down at 4000 g for 5 min. Cell pellets 
were resuspended in 200 µl of lysis buffer containing 
50 mM HEPES (pH 7.5), 150 mM NaCl, 2.5 mM 
EDTA, 1% Triton X-100 with Complete Mini Protease 
Inhibitor (Roche, Switzerland). 200 µl of glass beads 
(MP Biomedicals, USA) was added to the solution, 
then the cells were mechanically disrupted for 3 min 
on the FastPrep homogenizer (MP Biomedicals, USA) 
at 4°C. Afterwards, samples were centrifuged at 
13 000 g for 15 min at 4°C, and the supernatant was 
collected as lysate. Protein concentrations in the lysate 
were measured using a BCA protein assay kit (Thermo 
Scientific, USA) and 50 µg of protein for each sample 
was loaded on a 4–12% Bis-Tris gel (Invitrogen, 
USA). Primary antibodies 6E10 (anti-Aβ residues 1-
16, Covance, USA), anti-GFP (Roche, Switzerland), 
anti-Ub+1 (Santa Cruz, USA) and anti-GAPDH (Santa 
Cruz, USA) were used for immunoblotting. Blots were 
developed using ECL Prime reagents (GE Healthcare, 
USA) and scanned by ChemiDoc MP Imaging System 
(BioRad, USA). Images were quantified with Image J. 
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GFP-Atg8 processing assay 
 
S. cerevisiae strains harboring the pRS416 GFP-Atg8 
expression plasmid were grown to mid exponential 
phase (OD600 nm 0.5–0.6) in SD-Ura-His medium. Cells 
were washed in PBS once and cultured in SD-Ura-His 
medium, YNB (-N) medium and SD-Ura-His medium 
with 0.2 µM rapamycin respectively for 4 h at 30°C. 
Following incubation, 5 OD600 nm of cells were 
harvested for western blot analysis using anti-GFP 
antibody (Roche, Switzerland) and anti-GAPDH 
antibody (Santa Cruz, USA). The rest of cells were 
observed by Leica AF 6000 inverted fluorescence 
microscopy (Leica DMI4000B, Germany) using the 
DIC and FLUO-GFP filters. Images were processed 
with the Leica Application Suite (LAS) software. 
 
FM 4-64 staining 
 
As a lipophilic styryl dye, FM 4-64 specifically stains 
the vacuolar membrane in yeast based on the method 
described by Journo D et al. in 2008 [45]. Yeast cells 
(control, L-UBB+1, atg1∆_control and atg1∆_L-UBB+1 
strains) were cultured to mid exponential phase 
(OD600 nm 0.5–0.6) in SD-His medium. 5 OD600 nm units 
of cells were harvested and resuspended in 1 ml of YPD 
medium containing 4 µM of FM 4-64 dye (Invitrogen, 
USA). Cells were cultivated for 30 min at 30°C in the 
dark. Then cells were resuspended in 10 ml of YPD 
without FM 4-64 and incubated for 40 min at 30°C. 
After washing in 50 mM HEPES buffer (pH 7) twice, 
cells were resuspended in either SD-His medium or 
YNB (-N) medium containing 1 mM PMSF 
(Phenylmethylsulfonyl fluoride, Sigma Aldrich, USA) 
and 10 mM sodium citrate (pH 4.3). Rapamycin (MW 
914.17, Cat no. R8781, Sigma Aldrich, USA) treatment 
was done in SD-His medium with a final concentration 
of 0.2 µM. After 4 h incubation at 30°C, cells were 
washed and resuspended in YNB (-N) medium 
containing 10 mM sodium citrate (pH 4.3) and 
visualized by Leica AF 6000 inverted fluorescence 
microscopy (Leica DMI4000B, Germany) using the 
DIC and FLUO-RFP filters. Images were processed 
with the Leica Application Suite (LAS) software and 
the numbers of cells with intravacuolar staining were 
quantified. 
 
Chronological Life Span (CLS) assay 
 
CLS was determined as described previously [88]. 
Yeast strains were inoculated into 5 ml of SD-Ura, SD-
His or SD-Ura-His medium depending on the strain 
requirements and grown overnight. After 20 h, cells 
were diluted into 20 ml of fresh SD medium to an initial 
OD600 nm of 0.1. Cultures were grown under continuous 
shaking (200 rpm) at 30°C. After 48 h, maximal cell 
densities were reached and therefore this time point was 
considered as day 1. Subsequently, cellular viability 
was estimated by a CFU assay every two days until day 
15. Approximately 400 cells were plated onto SD plates 
and incubated at 30°C for 48 h. CFU was calculated as 
the number of colonies formed divided by the number 
of plated cells. 
 
Propidium iodide staining 
 
Cell death was measured by propidium iodide (PI, 
Thermo Fisher Scientific, USA) staining as previously 
described [28]. 0.5 OD600 nm of cells were taken at 
different time points (e.g., 1-, 3-, 6- and 9-days) during 
cultivation. Cells were washed once at 4000 g for 5 min 
with PBS and stained with 0.5 µg ml−1 of PI for 20 min 
in the dark. 5000 cells were analyzed for each sample 
with Guava flow cytometer (Merck, Germany). 




Strains were grown in SD-Ura or SD-His medium 
overnight at 30°C. Cultures were diluted into 20 ml of 
SD medium (OD600 nm 0.1) and grown to mid 
exponential phase (OD600 nm 0.5–0.6). Cells were spun 
down and fixed immediately with 5 ml of 4% 
formaldehyde, 50 mM KPO4 (pH 6.5) and 1 mM MgCI2 
for 2 h. After fixation, cells were washed in 5 ml of PM 
(0.1 M KPO4 pH 7.5 and 1 mM MgCI2) and 
resuspended in PMST (0.1 M KPO4 pH 7.5, 1 mM 
MgCI2, 1 M Sorbitol and 0.1% Triton X-100) to a final 
OD600 nm of 10. 100 µl of cells were incubated with 0.6 
µl of 2-mercaptoethanol and 1 mg ml−1 zymolyase 
(Zymo Research, USA) for 40 min at 37°C. Spheroplast 
suspension was added to a polylysine-coated cover 
glass. The cells were blocked in 0.5% BSA/PMST for 
30 min at RT, and incubated with primary antibody 
(6E10, Covance, USA) overnight at 4°C. After rinsing 3 
times with PMST, cells were incubated with secondary 
antibody (anti-mouse Alexa 488, Dako, Denmark) for 2 
h at RT in the dark.  Then cells were stained with 0.4 
mg ml−1 DAPI (4′,6-diamidino-2-phenylindole) for 5 
min in the dark. Images were acquired using Leica AF 
6000 fluorescence microscope (Leica DMI4000B, 
Germany), and processed with LAS software. 
 
Real-time quantitative PCR (qPCR) 
 
qPCR was performed as previously described [29]. 1 µg 
of total RNA was used for cDNA synthesis with the 
QuantiTect Reverse Transcription Kit (QIAGEN, 
Germany). 2 µl of synthesized cDNA was used as the 
template for qPCR reaction with a DyNAmo Flash 
SYBR Green qPCR kit (Thermo Fisher Scientific, 
USA). Threshold cycle (Ct) values were obtained and 
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the ∆∆Ct method was used to calculate the fold change 
in transcript levels. RNA levels were normalized to the 
housekeeping gene ACT1. The primer sets are listed in 




Significance of differences between strains were 
determined as mean ± SD using two-tailed student t tests. 
A p-value < 0.05 was considered statistically significant 
unless specified explicitly. All experiments were done in 
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Supplementary Figure 1. Principal Component Analysis (PCA). Histogram of variance for each PC shows that the first PC captures 
the largest variance of dataset, which is 91.94%. 
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Supplementary Figure 2. The Heatmap of consensus scores of selected gene sets in L-UBB+1 strain comparing to control 
strain during EX phase. Consensus score is the mean rank given each gene set by different GSA runs. A low score (e.g., 1) is a gene set 
that is ranked high by most of GSA methods. Gene sets that received a median consensus rank <10 in at least one class from five classes 
(distinct-directional down, mixed-directional down, non-directional change, mix-directional up and distinct-directional up), are included in 
the heatmap. The ranking of gene set was shown by colors. Gene sets clustered at the upper part are showing patterns of mostly down-
regulation whereas the gene sets in the lower part are showing patterns of mainly up-regulation. The scores are presented inside each cell 
of the heatmap. 
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Supplementary Figure 3. The Heatmap of consensus scores of selected gene sets in L-UBB+1 strain comparing to control 




Supplementary Figure 4. qPCR analysis of ATG1 mRNA expression in control strain and L-UBB+1 strain during EX phase. 
Nitrogen starvation was induced in YNB (-N) medium for 4 h after mid-EX phase. Results are normalized to ACT1 mRNA level in control strain and 
shown as average values ± SD from biological triplicates. The asterisk (*) indicates significant difference compared to control strain (p < 0.001). 
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Supplementary Figure 5. The transcriptional response of autophagy related genes upon the L-UBB+1 expression during EX 
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Supplementary Figure 6. Low UBB+1 expression reduces Aβ40 levels in the humanized yeast AD model. (A) Immunostaining 
analysis of Aβ40 localization and expression using the 6E10 Aβ specific antibody. Nuclei were stained blue by DAPI. Scale bar = 5 µm. (B) 
Western blot analysis of Aβ40 expression in unboiled cell lysates with 6E10 antibody. GAPDH was used as the loading control. (C) Relative 
Aβ40 band intensity was normalized to GAPDH and compared to the untreated Aβ40 strain. Results are shown as average value ± SD of 
three independent experiments. *p < 0.05. 
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Supplementary Tables 
 
Supplementary Table 1. Overrepresentation of autophagy associated processes with up-regulated genes in L-UBB+1 
strain. 
Category description 
No. of genes in dataset 
(EX/D6) 






Mitophagy (GO:0000422) 20/23 48 2.05/2.30 1.71 × 10−3/8.77 × 10−5 
Late nucleophagy 
(GO:0044805) 
11/13 20 2.7/3.12 2.91 × 10−3/1.52 × 10−4 
Nucleophagy (GO:0034727) 18/22 46 1.92/2.29 6.69 × 10−3/1.36 × 10−4 
Regulation of autophagy 
(KEGG:sce04140) 
8/11 17 2.76/3.63 1.61 × 10−2/1.72 × 10−4 
Positive regulation of 
macroautophagy (GO:0016239) 
7/8 12 2.87/3.20 2.09 × 10−2/4.96 × 10−3 
Autophagy (GO:0006914) 29/38 100 1.43/1.82 4.02 × 10−2/1.39 × 10−4 
p-value < 0.05 was used as a cutoff. 
 
Supplementary Table 2. Genes with significantly different expression in autophagy pathways (L-UBB+1 strain vs 
control strain) adjusted p-value <0.05 was used to identify significance. 






in Day 6 
Adjusted p-value 
in Day 6 
YGL180W ATG1 2.81 6.76E-06 2.56 9.56E-06 
YLL042C ATG10 0.68 2.03E-03 0.93 3.72E-04 
YPR049C ATG11 2.51 2.18E-06 2.29 2.62E-06 
YBR217W ATG12 1.28 7.76E-05 1.60 2.46E-05 
YPR185W ATG13 0.64 6.50E-04 0.84 1.42E-04 
YCR068W ATG15 1.55 7.40E-05 1.34 1.53E-04 
YLR423C ATG17 0.12 6.21E-01 0.66 2.30E-02 
YFR021W ATG18 −0.85 7.66E-04 −0.73 1.60E-03 
YOL082W ATG19 −2.65 6.84E-06 −1.63 6.21E-05 
YNL242W ATG2 0.84 2.74E-03 0.94 1.50E-03 
YDL113C ATG20 1.03 2.85E-04 1.49 3.84E-05 
YLR431C ATG23 1.06 2.41E-04 1.45 4.45E-05 
YLR189C ATG26 2.76 2.55E-06 2.86 2.20E-06 
YJL178C ATG27 −1.57 9.21E-05 −1.50 1.10E-04 
YNR007C ATG3 1.85 1.37E-05 2.32 5.42E-06 
YDR022C ATG31 0.73 3.32E-02 1.50 1.13E-03 
YIL146C ATG32 3.10 1.19E-06 3.26 8.45E-07 
YLR356W ATG33 0.13 7.64E-01 0.80 7.17E-02 
YOL083W ATG34 2.30 3.30E-04 3.06 6.93E-05 
YJL185C ATG36 1.46 9.96E-04 1.84 2.74E-04 
YLR211C ATG38 −0.50 3.27E-02 −0.30 1.60E-01 
YLR312C ATG39 4.15 1.36E-06 4.56 8.45E-07 
YNL223W ATG4 1.30 2.06E-05 1.49 1.10E-05 
YOR152C  ATG40 2.06 1.06E-04 2.53 3.52E-05 
YPL149W ATG5 −1.00 4.08E-05 −0.70 2.65E-04 
YPL120W ATG6 0.15 3.26E-01 0.33 4.75E-02 
YHR171W ATG7 0.35 2.96E-01 0.75 4.67E-02 
YBL078C ATG8 2.14 6.55E-05 2.88 1.48E-05 
YDL149W ATG9 1.48 1.29E-04 2.09 2.14E-05 
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YJL095W BCK1 0.42 3.54E-03 0.40 4.31E-03 
YML077W BET5 −1.20 1.84E-05 −1.04 3.49E-05 
YDR022C CIS1 0.73 3.32E-02 1.50 1.13E-03 
YGL215W CLG1 1.84 2.66E-05 1.38 1.08E-04 
YBR109C CMD1 −0.86 1.31E-02 −0.66 3.66E-02 
YFL024C EPL1 1.67 3.01E-05 1.32 9.73E-05 
YOR244W ESA1 2.03 6.59E-06 2.05 6.19E-06 
YNL127W FAR11 0.75 5.64E-04 0.64 1.35E-03 
YGR163W GTR2 0.19 1.23E-01 0.37 1.15E-02 
YGR223C HSV2 1.89 1.04E-05 2.21 5.53E-06 
YPL250C ICY2 −1.60 4.76E-04 −2.08 1.10E-04 
YHR082C KSP1 1.45 7.74E-06 1.37 9.32E-06 
YKR007W MEH1 0.72 3.39E-04 1.03 5.10E-05 
YPL140C MKK2 1.65 4.59E-06 1.69 3.99E-06 
YGL124C MON1 −0.60 9.36E-03 −0.58 1.07E-02 
YMR004W MVP1 0.68 3.33E-04 0.92 6.37E-05 
YEL062W NPR2 −0.55 6.86E-03 −0.78 1.17E-03 
YHR195W NVJ1 0.27 2.43E-01 0.66 1.60E-02 
YNL289W PCL1 −2.66 2.38E-05 −2.68 2.23E-05 
YHR071W PCL5 1.25 3.75E-03 1.11 6.53E-03 
YPL154C PEP4 −0.91 6.97E-03 −0.59 4.18E-02 
YOL001W PHO80 0.91 5.88E-05 1.04 2.82E-05 
YPL031C PHO85 −0.01 9.41E-01 0.33 3.20E-02 
YDR435C PPM1 0.52 3.15E-03 0.77 3.84E-04 
YNL330C RPD3 0.73 1.23E-03 0.69 1.60E-03 
YBL103C RTG3 0.66 6.03E-03 0.50 1.99E-02 
YPL085W SEC16 0.49 2.04E-03 0.46 2.72E-03 
YBL050W SEC17 1.08 4.36E-05 1.39 1.29E-05 
YNL272C SEC2 0.57 1.64E-03 0.59 1.42E-03 
YFL005W SEC4 0.28 4.12E-02 0.60 1.19E-03 
YBL058W SHP1 0.73 6.54E-04 0.93 1.72E-04 
YLR079W SIC1 0.70 5.67E-04 0.88 1.65E-04 
YBR077C SLM4 1.05 1.44E-04 1.39 3.25E-05 
YJL036W SNX4 1.41 1.89E-05 1.67 8.55E-06 
YAR042W SWH1 1.43 1.42E-04 1.40 1.49E-04 
YJR066W TOR1 0.55 2.66E-03 0.41 1.08E-02 
YKL203C TOR2 1.04 1.44E-04 0.86 3.77E-04 
YKR042W UTH1 0.84 9.09E-03 0.25 3.22E-01 
YDL077C VAM6 0.33 3.29E-02 0.35 2.71E-02 
YOR043W WHI2 0.64 1.00E-03 0.39 1.09E-02 
YPL120W VPS30 0.15 3.26E-01 0.33 4.75E-02 
YLR396C VPS33 −0.91 1.11E-04 −0.98 7.02E-05 
YOL105C WSC3 0.72 1.59E-03 0.37 3.11E-02 
YFL004W VTC2 0.55 8.50E-04 0.41 3.86E-03 
YPL019C VTC3 0.51 4.11E-02 0.61 2.08E-02 
YLR312C YLR312C 4.15 1.36E-06 4.56 8.45E-07 
YOR019W YOR019W 1.25 8.12E-04 1.40 4.32E-04 
YOR152C YOR152C 2.06 1.06E-04 2.53 3.52E-05 
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YFL038C YPT1 0.44 3.33E-03 0.54 1.10E-03 
YGL210W YPT32 0.54 1.15E-03 0.71 2.60E-04 
YML001W YPT7 −1.18 6.56E-05 −0.87 3.15E-04 
YHR030C SLT2 −1.27 1.24E-05 −1.40 6.15E-06 
 
 
Supplementary Table 3. Source data for Figures 5 and 7. 
Figure 5A 
Strain Day 1 Day 3 Day 5 Day 7 Day 9 Day 11 Day 13 Day 15 
control_1 343 306 329 249 75 24 13 24 
control_2 306 345 369 244 46 21 10 10 
LUBB+1-1 401 372 406 404 310 157 53  
LUBB+1-2 410 384 437 398 258 73 33  
atg1∆_LUBB+1-1 453 365 327 237 77 19   
atg1∆_LUBB+1-2 435 394 341 203 99 24   
atg1∆_1 355 281 302 246 118 3   
atg1∆_2 406 305 257 225 101 14   
 
Figure 7A 
 Day 1 Day 3 Day 5 Day 7 Day 9 Day 11 Day 13 Day 15 
control 1 343 306 329 249 75 24 13  
control 2 306 345 369 244 46 21 10  
Aβ42_1 393 313 94 39 7    
Aβ42_2 391 374 101 32 4    
Aβ40_1 458 348 278 110 40 7   
Aβ40_2 402 453 296 139 22 12   
Aβ42_LUBB+1_1 326 272 319 299 133 48 22 9 
Aβ42_LUBB+1_2 290 268 266 214 132 42 29 10 
Aβ40_LUBB+1_1 295 371 316 309 192 64 48 13 
Aβ40_LUBB+1_2 315 347 389 290 156 67 25 23 
 
Figure 7B 
 Day 1 Day 3 Day 5 Day 7 Day 9 Day 11 
atg1∆_Control_1 355 281 302 246 118 3 
atg1∆_Control_2 406 305 257 225 101 14 
atg1∆_Aβ 42_1 441 451 241 5   
atg1∆_Aβ 42_2 456 418 248 11   
atg1∆_Aβ 40_1 476 504 165 2   
atg1∆_Aβ 40_2 523 475 139 0   
atg1∆_Aβ 40_LUBB+1_1 354 300 209 154 68 5 
atg1∆_Aβ 40_LUBB+1_2 334 263 235 183 55 8 
atg1∆_Aβ 42_LUBB+1_1 368 289 218 160 72 17 
atg1∆_Aβ 42_LUBB+1_2 364 242 196 136 53 5 
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Supplementary Table 4. Primer-sets used in this study. 
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qPCR primers for ATG36 
 
 
Supplementary Table 5. Plasmids and Saccharomyces cerevisiae strains used in this study. 
Name  References 
Plasmid Characteristics  
p413 TEF CEN, TEF1 promoter, HIS3 marker [84] 
p413 TEF-UBB+1 p413TEF with UBB+1 sequence [27] 
p416 GPD CEN, GPD1 promoter, URA3 marker [84] 
p416 GPD-Kar2-Aβ42 p416GPD with Kar2 and Aβ42 sequences [28] 
p416 GPD-Kar2-Aβ40 p416GPD with Kar2 and Aβ40 sequences [28] 
pRS416 GFP-Atg8 pRS416 with GFP and Atg8 sequences [85] 
Strain Relevant genotype  
CEN.PK 113-11C MATα his3∆1 ura3-52 MAL2-8c SUC2 [82] 
Control CEN.PK 113-11C/p413 TEF  
L-UBB+1 CEN.PK 113-11C/p413 TEF-UBB+1  
Aβ42 CEN.PK 113-11C/p416 GPD-Kar2-Aβ42 [28] 
Aβ40 CEN.PK 113-11C/p416 GPD-Kar2-Aβ40 [28] 
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Aβ42_L-UBB+1 CEN.PK 113-11C/p416 GPD-Kar2-Aβ42/p413 TEF-UBB+1 This study 
Aβ40_L-UBB+1 CEN.PK 113-11C/p416 GPD-Kar2-Aβ40/p413 TEF-UBB+1 This study 
GFP_Atg8 CEN.PK 113-11C/p413 TEF / pRS416 GFP-Atg8 This study 
L-UBB+1_GFP_Atg8 CEN.PK 113-11C/p413 TEF-UBB+1/pRS416 GFP-Atg8 This study 
atg1∆ CEN.PK 113-11C/atg1::loxP-KanMX4-loxP This study 
atg1∆_Control atg1∆/p413 TEF This study 
atg1∆_L-UBB+1 atg1∆/p413 TEF-UBB+1 This study 
atg1∆_Aβ42 atg1∆/p416 GPD-Kar2-Aβ42 This study 
atg1∆_Aβ40 atg1∆/p416 GPD-Kar2-Aβ40 This study 
atg1∆_Aβ42_L-UBB+1 atg1∆/p416 GPD-Kar2-Aβ42/p413 TEF-UBB+1 This study 
atg1∆_Aβ40_L-UBB+1 atg1∆/p416 GPD-Kar2-Aβ40/p413 TEF-UBB+1 This study 
atg1∆_GFP_Atg8 atg1∆/pRS416 GFP-Atg8/p413 TEF This study 
atg1∆_GFP_Atg8_L-UBB+1 atg1∆/pRS416 GFP-Atg8/p413 TEF-UBB+1 This study 
 
 
 
 
